Your browser does not support iframes.
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Enzon Pharmaceuticals, Inc.
(NQ:
ENZN
)
1.700
USD
UNCHANGED
Official Closing Price
/ Updated:
4:00 PM EDT, Jun 19, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
1.730
Bid (Size)
1.700 (19700)
Ask (Size)
1.710 (6100)
Prev. Close
1.700
Today's Range
1.670 - 1.750
52wk Range
1.540 - 7.470
Shares Outstanding
43,729,062
Dividend Yield
N/A
Top News
More News
Vivus (VVUS) Sees Upside on Icahn Connection
May 23, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8365254 for the full story.
Read More
from
StreetInsider.com News Articles
ENZN July Options Begin Trading
May 20, 2013
Investors in Enzon Pharmaceuticals Inc (ENZN) saw new options become available today, for the July expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ENZN options...
Read More
category
Stocks
from
Market News Video
More News
Read More
Carl Icahn's Q1 13F Reveals Little New
May 15, 2013
from
StreetInsider.com News Articles
Klarman Baupost Gets Into Citi (C) Warrants, DIRECTV (DTV) and Elan (ELN); Cuts News Corp (NWSA)
May 14, 2013
from
StreetInsider.com News Articles
Free Research Reports on ENZN, FSLR, IRBT and MTH Issued by the Bedford Report
April 26, 2013
from
Marketwired News Releases
UPDATE: Enzon Reported Concluded Review of Possible Sale of Assets, Authorizes $1.60/Share Special Dividend, Periodic Royalty Dividends
April 23, 2013
category
Benzinga
,
ENZN
,
Dividends
, and 1 more.
from
Latest Articles from Benzinga.com
Enzon Pharmaceuticals, Inc. (ENZN) Declares $1.60 Special Dividend; 41.9% Yield
April 23, 2013
from
StreetInsider.com News Articles
Enzon Pharma (ENZN) Concludes Sale Review; Declares $1.60/Sh. Special Div.
April 23, 2013
from
StreetInsider.com News Articles
Enzon Concludes Review of Possible Asset Sales, Sale of the Company; Announces $1.60 Special Dividend and Periodic Royalty Dividends
April 23, 2013
from
Marketwired News Releases
Enzon Pharmaceuticals (ENZN) trading halted with news pending
April 23, 2013
from
StreetInsider.com News Articles
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.
Your browser does not support iframes.